Interleukin 12-activated lymphocytes influence tumor genetic programs

Interleukin 12-activated lymphocytes influence tumor genetic programs

Item
http://www.wikidata.org/entity/Q57693062
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceConcordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesionsThe IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice.Immune cells and angiogenesis."Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.L-Ferritin targets breast cancer stem cells and delivers therapeutic and imaging agents.Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses.
P2860

Interleukin 12-activated lymphocytes influence tumor genetic programs

Item
http://www.wikidata.org/entity/Q57693062
description
im April 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2001
@uk
name
Interleukin 12-activated lymphocytes influence tumor genetic programs
@en
Interleukin 12-activated lymphocytes influence tumor genetic programs
@nl
type
label
Interleukin 12-activated lymphocytes influence tumor genetic programs
@en
Interleukin 12-activated lymphocytes influence tumor genetic programs
@nl
prefLabel
Interleukin 12-activated lymphocytes influence tumor genetic programs
@en
Interleukin 12-activated lymphocytes influence tumor genetic programs
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P921
P1433
P1476
Interleukin 12-activated lymphocytes influence tumor genetic programs
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P921